![BMS 777607 Catalog No.:M10897-2 4'-piperidine]-1(32)](https://cdn.shopify.com/s/files/1/0389/1897/9723/products/M10897_1621562653.gif?v=1621562654)
Pay in 4 interest-free payments of $27.45 Learn more
Ships within 48 hours · Estimated delivery Jul 26 - Jul 31
4'-piperidine]-1(32)
Rottlerin induces cyclooxygenase-2 upregulation through an ATF4 and reactive oxygen species-independent pathway in HEI-OC1 cells
Infigratinib in patients with advanced cholangiocarcinoma with FGFR2 gene fusions/translocations: the PROOF 301 trial
also known as Olaparib or KU-59436
2ClH/c11-9(12)17-15-5-7-2-1-3-8(4-7)6-16-18-10(13)14
BMS 777607 Catalog No.:M10897-2 4'-piperidine]-1(32)BMS 777607, also known as BMS 817378 and ASLAN 002, a Met tyrosine kinase inhibitor, is an inhibitor of MET tyrosine kinase with potential antineoplastic activity. MET tyrosine kinase inhibitor BMS 777607 binds to c Met protein, or hepatocyte growth factor receptor (HGFR), preventing binding of hepatocyte growth factor (HGF) and disrupting the MET signaling pathway; this agent may induce cell death in tumor cells expressing c Met. c Met, a receptor